ESMO Open Oncology

Carboplatin in patients with metastatic castration-resistant prostate cancer harboring somatic or germline homologous recombination repair gene mutations: phase II single-arm trial (CIPHER)

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →